← Leaderboards
Navjot Pabla
Ohio State University
$3,928,551
Attributed
$7,701,102
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,701,102 · 4
By mechanism
R01$7,545,102 · 3
R03$156,000 · 1
Top collaborators
- Amandeep Bajwa5 shared
- Alexander Sparreboom5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Shuiying Hu$2,114,418
- Sharyn D Baker$10,060,478
- Maryam B. Lustberg$3,432,763
- Blake Peterson$11,402,719
- Daniel Addison$3,345,439
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsSmall MoleculePhosphotransferasesCellsIn VivoTubular FormationPharmaceutical PreparationsMediatingKidneyNephrotoxicityToxic EffectScreeningRna InterferenceProteinsIn VitroTissuesMouse ModelGeneticCell LineUptakeResponseBindingProteomicsInjury To Kidney
Grant awards (11)
Mitoprotective therapies for kidney injury$3,010,432
R01 · FY2025 · DK
Off target mechanisms of kinase inhibitor toxicities$490,462
R01 · FY2025 · DK · contact PI
Off target mechanisms of kinase inhibitor toxicities$477,614
R01 · FY2024 · DK · contact PI
Off target mechanisms of kinase inhibitor toxicities$504,428
R01 · FY2023 · DK · contact PI
Off target mechanisms of kinase inhibitor toxicities$525,584
R01 · FY2022 · DK · contact PI
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics$512,366
R01 · FY2021 · CA
Illuminating the biological functions of CDKL1 Kinase$156,000
R03 · FY2021 · TR · contact PI
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics$512,366
R01 · FY2020 · CA
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics$496,995
R01 · FY2019 · CA
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics$511,546
R01 · FY2018 · CA
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics$503,309
R01 · FY2017 · CA